WallStSmart

Dayforce Inc. (DAY)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Dayforce Inc. generates 631% more annual revenue ($1.89B vs $258.90M). DAY leads profitability with a -0.1% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

DAY

Hold

40

out of 100

Grade: D

Growth: 5.3Profit: 2.0Value: 5.0Quality: 5.0
Piotroski: 5/9Altman Z: 0.49

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DAYUndervalued (+23.8%)

Margin of Safety

+23.8%

Fair Value

$91.65

Current Price

$69.86

$21.79 discount

UndervaluedFair: $91.65Overvalued
ZEPPUndervalued (+48.8%)

Margin of Safety

+48.8%

Fair Value

$46.82

Current Price

$18.43

$28.39 discount

UndervaluedFair: $46.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DAY0 strengths · Avg: 0/10

No standout strengths identified

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

DAY4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
0.1%4/10

0.1% revenue growth

EPS GrowthGrowth
1.3%4/10

1.3% earnings growth

PEG RatioValuation
5.362/10

Expensive relative to growth rate

Return on EquityProfitability
-0.1%2/10

ROE of -0.1% — below average capital efficiency

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : DAY

DAY has a balanced fundamental profile.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : DAY

The primary concerns for DAY are Revenue Growth, EPS Growth, PEG Ratio.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

DAY profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 40/100) and 43.0% revenue growth. DAY offers better value entry with a 23.8% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dayforce Inc.

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Dayforce Inc., is a human capital management (HCM) software company in the United States, Canada, and internationally. The company is headquartered in Minneapolis, Minnesota.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?